STOCK TITAN

iHuman Inc. Files 2023 Annual Report on Form 20-F

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
iHuman Inc. (NYSE: IH) filed its 2023 Annual Report on Form 20-F, showcasing its financial performance for the year ended December 31, 2023. The report is available online and can be requested in hard copy. iHuman continues to be a key player in tech-powered intellectual development products in China.
iHuman Inc. (NYSE: IH) ha presentato il suo Rapporto Annuale 2023 sul Modulo 20-F, mettendo in luce le prestazioni finanziarie per l'anno conclusosi il 31 dicembre 2023. Il rapporto è disponibile online e può essere richiesto anche in copia cartacea. iHuman continua ad essere un attore principale nel settore dei prodotti per lo sviluppo intellettuale assistito dalla tecnologia in Cina.
iHuman Inc. (NYSE: IH) ha presentado su Informe Anual 2023 en el Formulario 20-F, destacando su rendimiento financiero para el año finalizado el 31 de diciembre de 2023. El informe está disponible en línea y se puede solicitar en copia impresa. iHuman sigue siendo un jugador clave en el mercado de productos para el desarrollo intelectual apoyados por tecnología en China.
iHuman Inc. (NYSE: IH)는 2023년 12월 31일로 마감된 연도의 재무 성과를 보여주는 2023년 연례 보고서(Form 20-F)를 제출했습니다. 보고서는 온라인으로 제공되며, 인쇄본도 요청할 수 있습니다. iHuman은 중국에서 기술 지원 지적 개발 제품 분야에서 계속해서 중요한 역할을 하고 있습니다.
iHuman Inc. (NYSE: IH) a déposé son Rapport Annuel 2023 sur le Formulaire 20-F, soulignant sa performance financière pour l'année se terminant le 31 décembre 2023. Le rapport est disponible en ligne et peut être demandé en version papier. iHuman continue d'être un acteur clé dans le domaine des produits de développement intellectuel assistés par la technologie en Chine.
iHuman Inc. (NYSE: IH) hat seinen Jahresbericht 2023 auf Formular 20-F eingereicht, der die finanzielle Leistung für das am 31. Dezember 2023 beendete Jahr zeigt. Der Bericht ist online verfügbar und kann auch in gedruckter Form angefordert werden. iHuman bleibt ein wichtiger Akteur in der Branche der technologiegestützten intellektuellen Entwicklung in China.
Positive
  • None.
Negative
  • None.

Insights

An analysis of iHuman Inc.'s recently filed annual report can yield insights into the company's fiscal health and strategic direction. The contents typically include detailed financial statements such as the balance sheet, income statement and cash flow statement. These reports are of prime importance, as they provide investors with a comprehensive view of the company's financial performance over the past fiscal year.

Investors would do well to scrutinize key figures like revenue growth, profit margins and earnings per share. Compare these against industry benchmarks to determine the company's competitive standing. For instance, significant deviations from sector averages in profit margins could indicate either operational efficiencies or cost management issues.

Furthermore, it's important to assess the company's liquidity and solvency through its current ratio and debt-to-equity ratio. Sudden changes in these indicators could suggest shifts in the company's financial stability. In the long term, sustained improvements in these metrics might hint at a positive trajectory, potentially impacting the stock's valuation.

Another aspect to consider is the company's market positioning and product pipeline highlighted within the annual report. Since iHuman specializes in educational technology, it's important to evaluate the evolving demand for such products in China and globally. Investors should consider demographics, government policies on education and technological adoption trends, as these factors can significantly influence iHuman's market potential.

Understanding the company's strategic initiatives, such as investments in new product development or geographic expansion, can offer clues about growth prospects. Market reactions often hinge on these forward-looking statements. Insights into the competitive landscape, including the market share and the intensity of competition, help in gauging iHuman's potential to outperform its peers.

BEIJING, April 25, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2023, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to iHuman Inc., Floor 8, Building B, No. 1 Wangjing East Road, Chaoyang District, Beijing 100012, People's Republic of China.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/.

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.com

Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-files-2023-annual-report-on-form-20-f-302127510.html

SOURCE iHuman Inc.

FAQ

What did iHuman Inc. (IH) announce regarding its annual report?

iHuman Inc. (IH) announced the filing of its 2023 Annual Report on Form 20-F for the year ended December 31, 2023.

Where can investors access iHuman Inc.'s (IH) annual report on Form 20-F?

Investors can access iHuman Inc.'s (IH) annual report on Form 20-F on the Company's investor relations website at https://ir.ihuman.com/.

How can shareholders and ADS holders request a hard copy of iHuman Inc.'s (IH) annual report on Form 20-F?

Shareholders and ADS holders can request a hard copy of iHuman Inc.'s (IH) annual report on Form 20-F by contacting iHuman Inc. at Floor 8, Building B, No. 1 Wangjing East Road, Chaoyang District, Beijing 100012, People's Republic of China.

iHuman Inc. American depositary shares, each representing five

NYSE:IH

IH Rankings

IH Latest News

IH Stock Data

90.08M
23.57M
0.62%
0.01%
Education & Training Services
Consumer Defensive
Link
United States of America
Beijing